Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Berk

Showing results (301-310 of 1,307) with videos related to

Pageof 131
Sort By:
Current Drug Safety|May 20, 2015
Prevalence of cardiovascular and metabolic events in patients prescribed clozapine: a retrospective observational, clinical cohort studyNatalie Hyde, Seetal Dodd, Kamalesh Venugopal, et al.
Psychiatry and Clinical Neurosciences|May 25, 2010
Do we need to flick the switch? The need for a broader conceptualization of iatrogenic course aggravation in clinical trials of bipolar disorderMichael Berk, Felicity Ng, Seetal Dodd, et al.
Journal of Affective Disorders|December 29, 2024
Psycho-biological mechanisms involved in suicidal risk, suicide attempts, and aggression: A replication and extension in bipolar disorderVahid Khosravani, Seyed Mehdi Samimi Ardestani, Michael Berk, et al.
Clinical Psychology & Psychotherapy|October 15, 2024
The Connections Between Alexithymia, Childhood Maltreatment, Impulsivity and Extreme Sensory Processing Patterns in Relation to Bipolar Symptoms in Inpatients With Bipolar DisorderMorteza Aghaeimazraji, Vahid Khosravani, Seyed Mehdi Samimi Ardestani, et al.
Bipolar Disorders|July 23, 2021
Why do medications with little or no efficacy continue to be prescribed in the management of patients with bipolar disorder?Fabiano A Gomes, Roumen Milev, Lakshmi N Yatham, et al.
Social Psychiatry and Psychiatric Epidemiology|November 20, 2012
Diet quality and mental health problems in adolescents from East London: a prospective studyFelice N Jacka, Catherine Rothon, Stephanie Taylor, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|February 26, 2020
Nutritional ketosis as an intervention to relieve astrogliosis: Possible therapeutic applications in the treatment of neurodegenerative and neuroprogressive disordersGerwyn Morris, Michael Maes, Michael Berk, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 1, 2020
The effect of combined treatment with SSRIs and renin-angiotensin system (RAS) drugs: A propensity score matched cohort studyOle Köhler-Forsberg, Liselotte Petersen, Michael Berk, et al.
Early Intervention in Psychiatry|January 29, 2019
Putative neuroprotective pharmacotherapies to target the staged progression of mental illnessOliver D Robertson, Nieves G Coronado, Rickinder Sethi, et al.
Bipolar Disorders|November 14, 2020
The rebirth of lithium as the archetypal mood stabilizerAndre F Carvalho, Marco Solmi, M Ishrat Husain, et al.
Pageof 131

Showing results (301-310 of 1,307) with videos related to

Sort By:
Pageof 131
Current Drug Safety|May 20, 2015
Prevalence of cardiovascular and metabolic events in patients prescribed clozapine: a retrospective observational, clinical cohort studyNatalie Hyde, Seetal Dodd, Kamalesh Venugopal, et al.
Psychiatry and Clinical Neurosciences|May 25, 2010
Do we need to flick the switch? The need for a broader conceptualization of iatrogenic course aggravation in clinical trials of bipolar disorderMichael Berk, Felicity Ng, Seetal Dodd, et al.
Journal of Affective Disorders|December 29, 2024
Psycho-biological mechanisms involved in suicidal risk, suicide attempts, and aggression: A replication and extension in bipolar disorderVahid Khosravani, Seyed Mehdi Samimi Ardestani, Michael Berk, et al.
Clinical Psychology & Psychotherapy|October 15, 2024
The Connections Between Alexithymia, Childhood Maltreatment, Impulsivity and Extreme Sensory Processing Patterns in Relation to Bipolar Symptoms in Inpatients With Bipolar DisorderMorteza Aghaeimazraji, Vahid Khosravani, Seyed Mehdi Samimi Ardestani, et al.
Bipolar Disorders|July 23, 2021
Why do medications with little or no efficacy continue to be prescribed in the management of patients with bipolar disorder?Fabiano A Gomes, Roumen Milev, Lakshmi N Yatham, et al.
Social Psychiatry and Psychiatric Epidemiology|November 20, 2012
Diet quality and mental health problems in adolescents from East London: a prospective studyFelice N Jacka, Catherine Rothon, Stephanie Taylor, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|February 26, 2020
Nutritional ketosis as an intervention to relieve astrogliosis: Possible therapeutic applications in the treatment of neurodegenerative and neuroprogressive disordersGerwyn Morris, Michael Maes, Michael Berk, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 1, 2020
The effect of combined treatment with SSRIs and renin-angiotensin system (RAS) drugs: A propensity score matched cohort studyOle Köhler-Forsberg, Liselotte Petersen, Michael Berk, et al.
Early Intervention in Psychiatry|January 29, 2019
Putative neuroprotective pharmacotherapies to target the staged progression of mental illnessOliver D Robertson, Nieves G Coronado, Rickinder Sethi, et al.
Bipolar Disorders|November 14, 2020
The rebirth of lithium as the archetypal mood stabilizerAndre F Carvalho, Marco Solmi, M Ishrat Husain, et al.
Pageof 131